Replimune Group, Inc.
REPLNASDAQHealthcare● Active
$8.97
$-0.50(-5.28%)
Market Cap$740676392
P/E Ratio—
52W High$13.24
52W Low$1.5
Replimune Group, Inc. (REPL) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · REPL · as of 2026-06-10
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.25B) | ($0.22B) | ($0.17B) | ($0.12B) | ($0.08B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.04B | $0.03B | $0.03B | $0.02B | $0.01B |
| Change in Working Capital | $0.02B | $0.01B | $0.02B | $0.01B | $0.00B |
| Net Cash from Operations | ($0.19B) | ($0.19B) | ($0.13B) | ($0.08B) | ($0.06B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.01B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.40B) | ($0.49B) | ($0.58B) | ($0.26B) | ($0.39B) |
| Sales of Investments | $0.39B | $0.59B | $0.44B | $0.26B | $0.21B |
| Net Cash from Investing | ($0.02B) | $0.10B | ($0.14B) | ($0.00B) | ($0.19B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($0.00B) | $0.01B | $0.03B | ($0.00B) | ($0.01B) |
| Net Cash from Financing | $0.25B | $0.02B | $0.31B | $0.01B | $0.37B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.20B) | ($0.19B) | ($0.13B) | ($0.08B) | ($0.06B) |
| FCF Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Replimune Group, Inc. data
About Replimune Group, Inc. (REPL) Cash Flow Statement
Replimune Group, Inc. generated operating cash flow of ($0.19B) and free cash flow of ($0.20B) for 2025 — a FCF margin of —. Capital expenditure was ($0.01B).
Frequently asked questions
REPL · 4 questionsReplimune Group, Inc. generated free cash flow of ($0.20B) for 2025, down 4.1% year-over-year.
REPL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10